2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Dr Levy presents updated safety and efficacy results on larotrectinib in patients with TRK fusion-positive lung cancer.
Related Content: